• There are no suggestions because the search field is empty.

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?

person-image
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager and Sara Peeters, Senior Consultant IVD - Performance Evaluation Studies

Discover why usability testing is essential for compliance and safety in Near-Patient and self-testing devices under the IVDR. Learn key guidelines, study designs, and tips for successful usability evaluations.

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?
8:31

 

It shouldn’t be a surprise that today, “Near-Patient Testing (NPT)” and “self-testing” are considered two of the most rapidly expanding markets within the “In Vitro Diagnostic (IVD)” segment. These testing methods offer greater convenience, faster results, and more accessible healthcare solutions, meeting the increasing demand for personalized, on-the-spot diagnostics. The rise of NPT and self-testing has been especially evident during the “SARS-CoV-2 pandemic”, where these tools proved their value by enabling rapid diagnosis and disease management across various settings, both in developed and emerging markets.

 

Definition Self-Test:

Any device intended by the manufacturer to be used by lay persons, including devices used for testing services offered to laypersons by means of information society services. Source IVDR Art. 2(5)

Note: self-tests are predominantly used by laypersons at their own home

Definition NPT test:

Any device that is not intended for self-testing but is intended to perform testing outside a laboratory environment, generally near to, or at the side of the patient by a health professional. Source IVDR Art. 2(6)

Note: NPT is often also referred to as Point-of-Care Testing (PoCT).

With the implementation of the In Vitro Diagnostic Medical Device Regulation (EU IVDR) 2017/746, NPT and self-test devices, just like any other IVD device, need to apply for conformity assessment and obtain CE marking before entering the EU market. Usability engineering/testing plays an important role in this assessment. Under the IVDR, usability is not only a matter of user convenience but also of safety, ensuring that devices can be used correctly by healthcare professionals and laypersons alike.

IVDR Article 9.4 and 19 mandates that the performance of IVD devices must be demonstrated under normal conditions, specifically considering the intended user and use environment. This makes usability testing a key component in regulatory approval, especially for NPT and self-testing devices.

 

The usability engineering process under IVDR consists of two pillars: Formative usability and Summative usability.

 

Formative Usability

This stage is part of the design and development process and aims to improve device design through user feedback and error analysis. Activities include:

  • Task and error analysis
  • Design failure mode and effects
  • analysis (DFMEA)
  • Cognitive walkthroughs
  • Prototype testing

Formative usability testing follows an iterative process where results are continually fed back into the design, improving both safety and user experience.

Summative Usability

This phase is part of the clinical evaluation and aims to validate the final usability of the product. It focuses on ensuring that the device can be successfully used by all intended users in all expected conditions.

Summative usability testing is conducted to:

  • Demonstrate that intended users (professionals and laypersons) can reliably use the device as instructed.
  • Identify residual risks by observing users during testing and noting any errors.

At this stage, the testing is aligned with regulatory requirements to prove that the product is ready for market approval.

In the remainder of this blog post, we are going to focus on this second pillar.

Conducting a summative usability study is an important step in bringing NPT and self-testing devices onto the market. Not only the user environments and user requirements but also the education and skill levels of the different users should be considered early in the process.

During summative usability testing, the performance of NPT and self-testing devices should be conducted in relevant environments. This to demonstrate that the test can be used reliably at the claimed user settings such as for example, the laboratory, the doctor’s office, emergency units, etc., or by laypersons at their own homes.

 

When should you start your summative usability evaluation?

 

  • The finished product or a product representative of the finished product should be available. This includes demonstrated analytical performance, validated software, EMC and LV validation etc.
  • The intended purpose, intended user, and intended use environment should be clearly defined.
  • Final instructions for Use should be available.



What are key elements to consider when designing usability studies?

  • Intended use and user: Clearly define the intended user (health professionals or laypersons) and the use environment (home, clinic, emergency units, etc.).
  • Test conditions: Usability testing must replicate real-life conditions, including how the device is used by both professionals and laypeople.
  • Sample collection: For NPT and self-testing devices, sample collection is crucial. Ethics committee approval is often required to conduct studies involving sample collection.



How to design your summative usability study?


For NPT and self-testing devices, the following blocks are considered crucial in your study design (Figure 1).

  1. Demonstration of test performance by the intended user. Can the intended user correctly perform the test using the provided instructions for use? For this part, testing in the intended user setting can be compared with professional testing. During testing, the NPT user or laymen is observed by a trained and skilled operator (e.g. laboratory technician. This way, possible use errors can be observed and recorded.
  2. Interpretation study. Since an individual user will receive only one test result on their NPT test/self-test, users should be asked to interpret pre-developed test devices including all possible test results (e.g. negative, positive, and invalid test result). Each user must be able to interpret each possible test result without error.
  3. Questionnaire-based surveys. Making use of surveys is an easy and convenient way to assess whether the users reliably and correctly perform the test. These surveys will allow you to evaluate the ease of use and user satisfaction. Not only surveys for the users but also for the people observing the users can be included to assess whether the test was conducted correctly and as described in the instructions for use. The observer questionnaires should ideally be combined with post-test interviews to capture possible difficulties experienced by the users during testing.

 

Which guidelines to follow?


The usability testing process should follow the guidelines provided by recognized standards such as:

  • IEC 62366-1:2015 (Medical devices – Application of usability engineering to medical devices)
  • FDA’s Human Factor Engineering Guidance

These documents provide detailed frameworks on how to ensure that devices are safe and easy to use.

 

Some important takeaways from these guidelines:

  • Include representatives from all identified user groups.
  • Include all tasks and user interface characteristics for which potential use errors, possibly impacting the safety and effectiveness of the design, have been identified.
  • Include tasks that are essential for the operation of the device.
  • Perform usability testing in the actual setting or in a realistic simulated environment.
  • Assess the completion of tasks and gather subjective data on safety and ease of use.

 

For certain high-risk Class D IVD devices, the IVDR specifies common requirements that include additional performance characteristics for self-testing devices. Adhering to these guidelines is therefore also essential for ensuring compliance in usability studies.

How can we help with setting up your usability study?

 

We can support you in the setting up of your usability study. Depending on your test and the intended use environment, we will define together with you the test setting and intended users for your usability evaluation.

Once the design has been finalized, all study documentation (incl. study plan, questionnaires etc.) will be completed for the study to start.

We will provide the necessary training to the study staff before the start of the study and will make sure the necessary monitoring activities will be conducted.

The test will be performed according to the defined study plan and results will be collected and evaluated. All results will be summarized in a final written report.


Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Resources

preview_image
Webinar

PMS & PMCF Compliance for Medical Devices Under EU MDR

Join our expert-led webinar series on September 9 and 23 and discover how to turn PMS & PMCF compliance into clinical and strategic advantage — with exclusive insights from a notified body.
preview_image
Case study

Multiplex Respiratory Antigen Test: Accelerating IVDR Market Access

Fast-track your IVDR market access with our expertise. We help clients navigate regulatory hurdles to launch innovative diagnostic solutions efficiently and effectively.
preview_image
Case study

Building a Unified QMS for a Non-Profit Lab Organization

A non-profit lab organization unified its quality management processes by implementing a validated SAAS QMS, enhancing compliance and efficiency across departments.
preview_image
Case study

Agile Validation Support for a Global Life Sciences Organization

Discover agile validation support for life sciences, enhancing compliance and efficiency through a scalable, on-demand model tailored to your IT validation needs.
preview_image
Case study

Faster Market Entry Through Integrated IVDR and WHO Strategy

Accelerate your market entry with our integrated IVDR and WHO strategy, ensuring compliance while minimizing costs and sample size for diagnostic tests.
preview_image
Case study

Multiplex STI PCR Test: Supporting a Smooth IVDR Journey

Learn how we supported a global IVD manufacturer in achieving IVDR compliance for their multiplex STI PCR test, ensuring timely CE-marking and future regulatory confidence.
preview_image
Whitepaper

Digitalization in the Pharmaceutical Industry: And How to Stay Compliant

Digitalization and Pharma 4.0 drive digital transformation. Explore the role of CSV in pharma's digital journey.
preview_image
Whitepaper

The Essential CSV & Digitalization FAQ for Life Sciences Companies

Get clear answers to real CSV questions from clients & experts. Download our FAQ and stay compliant, audit-ready, and confident in your Software Validation Strategy.
preview_image
Whitepaper

Audit Trail Review in GxP Environments

Learn how to implement a risk-based Audit Trail review strategy to enhance software compliance in GxP environments.
preview_image
Case study

Validating a Complex Autoclave Load to Enhance Sterilization Efficiency

Discover how QbD Group helped a pharmaceutical facility in Barcelona optimize and validate a complex autoclave load, improving sterilization efficiency and manufacturing flexibility.
preview_image
Case study

Fast-Tracked Site Qualification for Clinical Trial Submission

QbD Group helped a biotech company complete 5 site qualification visits in just 3 weeks enabling a timely and compliant clinical trial submission.
preview_image
Webinar

Pharmacovigilance and Risk Management in Innovative Therapies: A Challenge in Drug Safety

Explore pharmacovigilance in cell, CAR T, and RNA therapies. Join our webinar to tackle tomorrow’s drug safety and risk management challenges.
preview_image
Webinar

Extractables & Leachables in Pharma: Navigating Evolving Regulations and Toxicological Challenges

This webinar aims to provide a comprehensive overview of Extractables and Leachables (E&L) in pharmaceutical products, highlighting regulatory complexities, toxicological challenges, and practical approaches to study design and risk assessment across the product lifecycle.
preview_image
Whitepaper

A Complete Guide to Computer System Validation

This guide aims to bring context and define the necessary and appropriate strategies for the validation of computerized systems. Download now.
preview_image
Whitepaper

Digital Health - Exploring the landscape and future opportunities

This whitepaper informs you about digital health, key technology pillars, and new opportunities to anticipate future trends in your healthcare sector.
preview_image
Whitepaper

ISO 13485:2016 - Compliance Checklist

Are you up to date with the latest medical device QMS requirements? Download our free ISO 13485:2016 checklist to ensure compliance.
preview_image
Case study

Enhancing data integrity & aseptic manufacturing compliance

QbD Group helped a leading medical tech company improve MDR compliance and enhance aseptic manufacturing for long-term regulatory readiness.
preview_image
Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.
preview_image
Whitepaper

ICH Stability Studies on Pharmaceuticals

This whitepaper discusses the importance of different methods for testing the stability of pharmaceutical products, stability study guidelines, and other aspects related to the stability of pharmaceutical products.
preview_image
Whitepaper

EU GMP: How to import your products into the EU?

Are you a medicinal product manufacturer looking to import your products into the EU in line with the latest EU-GMP import regulations? Download our guide.
preview_image
Case study

Scalable MSAT validation support for seamless compliance & efficiency

Discover how QbD Group helped a global pharmaceutical company address fluctuating validation demands across multiple teams.
preview_image
Case study

Restoring manufacturing timelines through expert deviation management

Discover how QbD Group helped a leading biotechnology company overcome a backlog of deviations, restoring timely batch release through expert QA support.
preview_image
Case study

Guiding a global biotech company through ATMP facility qualification

Discover how QbD Group supported a global biotech company in commissioning and qualifying two ATMP therapy production sites, ensuring compliance and efficiency.
preview_image
Whitepaper

How to keep computerized systems in the operational phase

Ensure compliance and efficiency with best practices for maintaining computerized systems in the operational phase. Download our expert whitepaper now!
preview_image
Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.
preview_image
Webinar

Evidence Throughout the Lifecycle: Integrating Clinical Needs into Design & Documentation

Discover how to integrate clinical needs into medical device software design to meet MDR requirements. Watch our webinar on demand.
preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Webinar

From Requirements to Code: a unified MDSW development cycle that covers all requirements

Watch our webinar on demand to master medical device software development. Learn about IEC standards, cybersecurity, AI integration, and FDA expectations.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Webinar

From Concept to Market: Comprehensive Market Access Strategies for Medical Device Software

Learn how to launch your Medical Device Software successfully with expert insights on market access and commercialization strategies. Watch our webinar on demand.
preview_image
Whitepaper

State-of-the-art literature review: kick off the Clinical Evaluation of your Medical Device

This whitepaper will walk you through the steps of conducting solid systematic SOTA literature searches for your clinical evaluation. Download now.
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Whitepaper

The pathway from idea to patient under MDR

This guide explains the pathway and steps needed to test your device in human subjects, aiming to get your product to market. Download now.
preview_image
Webinar

Unlocking Strategic Value in Drug Safety for Life Sciences Organizations

Explore how drug safety teams can transform into proactive benefit drivers with the right tools & resources in this webinar on demand.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.
preview_image
Whitepaper

GAMP 5 Software Validation Approach for GMP, GCP and GLP regulations

Learn how to comply with GMP, GCP, and GLP regulations using the GAMP 5 Software Validation Approach. Download the whitepaper for more insights.
preview_image
Webinar

How to manage mandatory communication of Toxicological Risks?

Learn how to effectively manage toxicological risks in the pharmaceutical industry by addressing, reporting, and mitigating potential harm.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Whitepaper

Standards and regulations for software used in Medical Devices

Explore the essential standards and regulations for software used in Medical Devices, including IEC 62304 and IEC 82304. Download now.
preview_image
Webinar

Setting up ATMP Quality Management Systems: Strategies for Compliance and Success

Discover strategies for establishing a compliant and successful ATMP Quality Management System. Watch our webinar on demand.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Webinar

The Basic Concepts of the QbD Methodology

Learn the basics of QbD methodology with industry experts in this on-demand webinar.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Webinar

ATMP Supply Chain: Navigating the Challenges and Exploring the Vein-to-Vein Strategy

Explore the transformative ATMP journey and vein-to-vein strategy in our webinar. Learn how to navigate challenges and unlock the full potential of ATMPs.
preview_image
Whitepaper

Achieving laboratory compliance

This whitepaper explores the multifaceted aspects of laboratory compliance, including data integrity, quality control measures, and regulatory adherence.
preview_image
Whitepaper

Annual Product Quality Review in Pharma

Want to learn more about the importance, benefits, and key challenges related to the Annual Product Quality Review in Pharma? Then read on quickly!
preview_image
Whitepaper

New GMP Facility Qualification: set-up, process and best practices

This whitepaper delves into the challenges of establishing a new GMP facility, focusing on potential pitfalls and best practices. Download now.
preview_image
Whitepaper

The One-Vigilance strategic roadmap to corporate excellence

This whitepaper introduces the concept of One Vigilance within the context of the current drug safety landscape. Download now.
preview_image
Case study

Guiding KU Leuven's glioblastoma research to the clinic with precision business planning

Helping KU Leuven advance glioblastoma research to the clinic with strategic business planning, funding support, and a roadmap for clinical impact.
preview_image
Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.
preview_image
Whitepaper

21 CFR Part 11 compliance checklist

Want to assess whether a computer system generates electronic records and uses electronic signatures, and whether the system complies with Part 11 of 21 CFR? Download this free checklist.
preview_image
Whitepaper

Ensuring compliance and quality in Pharmacovigilance

The whitepaper emphasizes the importance of a robust pharmacovigilance QMS and a well-maintained Pharmacovigilance System Master File (PSMF). Download now.
preview_image
Webinar

Second edition of GAMP 5: A Risk-Based Approach to compliant GxP Computerized Systems

This webinar on demand will tell you more about the second edition of GAMP 5.
preview_image
Whitepaper

Organic and mutagenic impurities in pharma

Ensure pharmaceutical quality and safety by controlling organic and mutagenic impurities. Download this whitepaper to learn more.
preview_image
Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.
preview_image
Webinar

Verification & Validation of Artificial Intelligence/ Machine Learning Medical Devices

Explore the impact of Artificial Intelligence and Machine Learning on medical device validation and verification processes.
preview_image
Whitepaper

GAMP categories for computerized systems: what are they and what are they for?

In this whitepaper, you will learn what GAMP is, what GAMP categories are for, and where to start if you are facing computerized systems validation.
preview_image
Whitepaper

Analytical Method Validation

In this whitepaper, we will give an overview of the criteria to consider when validating your analytical method.
preview_image
Whitepaper

EUDRALEX Volume 4 Annex 11 Compliance Checklist

Assess your computer system's compliance with EudraLex Volume 4 Annex 11 guidelines using our checklist. Download now for GMP assurance.
preview_image
Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.
preview_image
Whitepaper

From V-model to Agile: how to embrace automation as part of the computerized system validation approach

This white paper explores why IT is shifting to agile, focuses on the prevalent Scrum methodology, and concludes with guidance on adapting system validation processes.
preview_image
Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.
preview_image
Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.
preview_image
Case study

Optimizing pharmacovigilance for a biotechnology leader

Discover how QbD Group improved pharmacovigilance for a global leader in biotechnology, ensuring regulatory compliance and patient safety.
preview_image
Case study

Ensuring timely launch: QbD Group's role in establishing a hemophilia drug production line

QbD Group has facilitated the launch of a new drug production line for treating hemophilia, overseeing the qualification of over 100 pieces of small-scale supporting equipment.
preview_image
Case study

Ensuring pharmaceutical production quality: cleaning validation for government agency

Discover how QbD Group helped a client tackle dual validation challenges for their production lines, ensuring GMP compliance and AEMPS approval.
preview_image
Case study

Revolutionizing pharmacovigilance: a success story of strategic partnership and seamless integration

Discover how QbD Group's expert support enhanced a pharmaceutical company's pharmacovigilance, leading to a favorable inspection outcome by the local Regulatory Authority (AEMPS).
preview_image
Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Patient Support Program (PSP)

Learn about our patient support program (PSP) and how it helps manage customer support for a PV Spanish client. Resolve quality issues and ensure stability with QbD Pharma.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.
preview_image
Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.
preview_image
Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.
preview_image
Case study

Helping Abraca BioSystems to obtain ISO 13485 certification

QbD Group helped Abraca Biosystem gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Help BioLizard build their Quality Management System

QbD Group helped BioLizard document the fundamental processes of their QMS and enabled them to continue building it on their own.
preview_image
Case study

Supporting Oncomfort in developing and certifying their ISO 13485 QMS

QbD Group helped Oncomfort quickly implement and certify an ISO 13485 compliant Quality Management System.
preview_image
Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.